The Independent Scientific Oversight Committee (ISOC) is responsible for monitoring, evaluating and communicating publicly the results of the Canadian Fabry Disease Initiative Study (CFDI).   

ISOC Members

Scientific Members

Dr. Joseph Muenzer (Chair)
Professor of Pediatrics & Genetics
University of North Carolina at Chapel Hill
United States of America

Dr. Edmond Wraith
Consultant Paediatrician
Willink Biochemical Genetics Unit
Royal Manchester Children's Hospital
England

Dr. Carla Hollak
Internist, Department of Internal Medicine
Division of Endocrinology and Metabolism
Academic Medical Center
Amsterdam
The Netherlands

Dr. Grant Mitchell
Researcher
Service de génétique médicale/Service of Medical Genetics
Centre hospitalier universitaire mère-enfant (CHU) Sainte-Justine
Montréal, Québec
Canada

Ex-officio Members

Health Canada

Stephanie Priest (to October, 2008)
Senior Policy Advisor
Pharmaceutical Policy
Health Care Policy Directorate
Health Canada

Amanda Moir (from October, 2008)
Senior Policy Analyst
Pharmaceuticals Management Strategies
Strategic Policy Branch
Health Canada

Provinces 

Angie Wong (to May, 2009)
Senior Manager
Pharmaceutical Services Coordination
Public Drug Programs
Ontario Health and Long-Term Care

Brent Fraser (from May, 2009)
Director
Drug Program Services
Public Drug Programs
Ontario Health and Long-Term Care

Fonds de la recherche en santé du Québec (FRSQ)

Dr. Louise Roy
Department of Nephrology
Hospital St-Luc of CHUM
Montréal, Québec

Canadian Institutes of Health Research (CIHR)

Stephanie Robertson (to February, 2009)
Assistant Director
Institute of Genetics
Canadian Institutes of Health Research

Allison Jackson (from February, 2009)
Assistant Director
Institute of Genetics
Canadian Institutes of Health Research

Secretariat

Sheila Chapman
Project Manager
Expensive Drugs for Rare Diseases Initiative
Clinical Research Unit, Research Portfolio
Canadian Institutes of Health Research

Colette Paré
Project Officer
Expensive Drugs for Rare Diseases Initiative
Clinical Research Unit, Research Portfolio
Canadian Institutes of Health Research